Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 30, 2013

Qiagen Snaps Up Ingenuity for $105M

  • Qiagen has acquired Ingenuity Systems, provider of software solutions for the analysis and interpretation of genomic data, in a $105 million cash deal. Through this acquisition, Qiagen inherits Ingenuity’s portfolio of products derived from its Knowledge Base initiative—a 14-year effort to curate, model, and structure biomedical data, including genomic variations implicated in disease,computationally—including Ingenuity Pathways Analysis™, Ingenuity Variant Analysis™, and Ingenuity iReport™.

    According to Ingenuity, the company’s “Knowledge Base and software applications enable users to accurately interpret the meaning of increasingly large amounts of biological data to better guide scientific experiments and medical treatment decisions.”

    In a statement, Peer Schatz, Qiagen CEO said that “the interpretation of biological information is becoming a cornerstone of Qiagen's ecosystem of Sample & Assay Technologies for molecular testing—both in life sciences research and in diagnostics.” Speaking of the acquisition, he added: “We are looking forward to expanding the seamless integration of leading biomedical information solutions into our full range of molecular testing solutions, thereby providing our customers a unique experience from sample to interpreted result and recommendations for next steps.”

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »